• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Thera (NQ: VKTX )

    72.54 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Viking Thera

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    18 19 Next >
    3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
    These biotech stocks have promising outlooks that will bring major fortune to investors. Buy before it is too late. 
    Via InvestorPlace
    Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
    Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996 trial results for type 2 diabetes and obesity. Get insights into the latest... 
    Via Benzinga
    Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity
    Via Benzinga
    Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
    Via Benzinga
    Viking Therapeutics Unusual Options Activity For June 25
    Via Benzinga
    Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
    Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run company Linde. 
    Via Benzinga
    Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
    Roche released early-stage data on its oral weight-loss drug. 
    Via Investor's Business Daily
    Is Viking Therapeutics the Best Biotech Stock for You?
    Let's look beyond the hype the company is generating this year. 
    Via The Motley Fool
    The 3 Most Undervalued Biotech Stocks to Buy in July 2024
    There’s always a strong case for undervalued biotech stocks especially with newer innovation and demand for better treatment. 
    Via InvestorPlace
    Is Viking Therapeutics Stock Running Out of Steam?
    Viking's stock has tripled in less than a year, and its red-hot valuation could have investors thinking twice about buying it today. 
    Via The Motley Fool
    Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
    Both competitors have promising lead programs, and enough cash, too. 
    Via The Motley Fool
    Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
    Global pharmaceutical company Eli Lilly & Co. (NYSE: LLY) has been in a GLP-1 arms race with its FDA-approved therapies Mounjaro and Zepbound. It's been 
    Via MarketBeat
    Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
    This pharma company is posting double-digit revenue growth. 
    Via The Motley Fool
    3 Overlooked Giants-in-the-Making for Patient Investors
    Consider buying into these overlooked growth stocks for long-term profits that will help to boost a portfolio and deliver riches. 
    Via InvestorPlace
    The 7 Best Under $10 Stocks to Buy in July 2024
    We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now. 
    Via InvestorPlace
    Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
    Eli Lilly is a good stock to buy, but these should be even better. 
    Via The Motley Fool
    S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June’s sharply lower-than-expected services sector... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    3 Biotech Moonshots With Imminent Catalyst Potential
    Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts. 
    Via InvestorPlace
    Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
    Clinical-state biopharmaceutical company Altimmune Inc. (NASDAQ: ALT) focuses on developing peptide-based therapeutics for obesity and chronic liver diseases 
    Via MarketBeat
    Exposures Product Safety
    Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
    Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy 
    Via MarketBeat
    Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
    Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. 
    Via MarketBeat
    Exposures Product Safety
    Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
    It's a tough act to follow. 
    Via The Motley Fool
    3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
    While their share prices have traveled different paths recently, the similarity between the two companies is striking. 
    Via The Motley Fool
    The 3 Smartest Biotech Stocks to Buy With $5K Right Now
    With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. 
    Via InvestorPlace
    The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
    Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector. 
    Via InvestorPlace
    Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
    These healthcare stocks have clear paths to growth over the next few years. 
    Via The Motley Fool
    Better Growth Stock: Archer Aviation or Viking Therapeutics?
    Which one of these potential disruptors is the better buy? 
    Via The Motley Fool
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    18 19 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.